Royal Fund Management »

Amylyx Pharmaceuticals shares owned by Royal Fund Management

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Royal Fund Management from 13F filings

Historical chart of Royal Fund Management investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by Royal Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by Royal Fund Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $53k 19k 2.84

More positions owned by Royal Fund Management

Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard World Mega Grwth Ind (MGK)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Vanguard World Consum Stp Etf (VDC)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Specialized Funds Div App Etf (VIG)
Vanguard Index Fds Large Cap Etf (VV)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
JPMorgan Chase & Co. (JPM)
Vanguard Scottsdale Fds Vng Rus1000idx (VONE)
Coinbase Global Com Cl A (COIN)
Select Sector Spdr Tr Energy (XLE)
Vanguard World Inf Tech Etf (VGT)
Apple (AAPL)

View all positions for Royal Fund Management

Top funds holding Amylyx Pharmaceuticals

Vanguard Group
Viking Global Investors
Point72 Asset Management
Millennium Management
Citadel Advisors
Ikarian Capital
Perceptive Advisors
Franklin Resources
Goldman Sachs Group
Jane Street
Eventide Asset Management
Jupiter Asset Management
Marshall Wace
T. Rowe Price Associates
Deutsche Bank Aktiengesellschaft

View all funds holding Amylyx Pharmaceuticals